BioCentury
ARTICLE | Company News

Paladin sales and marketing update

December 19, 2011 8:00 AM UTC

Paladin launched DigiFab in Canada to treat digoxin toxicity or overdose. Health Canada approved the polyclonal antibody against digoxin (digitalis) glycosides for the indication in January. Details were not disclosed (see BioCentury, Feb. 7). ...